• Feedback
  • RSS Feed
  • Sitemap
Ommcom News
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ
No Result
View All Result
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ
No Result
View All Result
Odisha News, Odisha Breaking News, Odisha Latest News || Ommcom News
Home Science & Tech

Covaxin Shows Excellent Safety Track Record: Bharat Biotech On Study Citing Risks

OMMCOM NEWS by OMMCOM NEWS
May 16, 2024
in Science & Tech

New Delhi:  Several studies on Covaxin have demonstrated an excellent safety track record, said Bharat Biotech on Thursday, after a study raised concerns of stroke and Guillain-Barre syndrome (rare autoimmune disorder that affects the nerves) a year after taking the Covid-19 vaccine.

The study, led by Banaras Hindu University (BHU), claimed that Covaxin raised the rare risk of stroke, and Guillain-Barre syndrome, among others.

“Several studies have been executed on the safety of Covaxin, and published in peer-reviewed journals, demonstrating an excellent safety track record,” the Hyderabad-based drug-maker said in a statement.

The company noted that for such a study in safety to be effective, informative and to avoid investigator bias: “AESI (adverse events of special interest) safety profile of the subjects prior to participation in the study has to be kept in mind.

“Comparison of the safety profile of non-vaccinated subjects during the course of the study, comparison of the safety profile of subjects who received other vaccines during the course of the study, and all study participants should be followed during the course of the study, instead of only a subset,” Bharat Biotech added.

Recently, AstraZeneca admitted in the UK High Court about rare risk of blood clot disorder due to its Covid vaccine called Thrombotic Thrombocytopenic Syndrome (TTS) — a blood clot disorder.

Meanwhile, AstraZeneca’s vaccine, made in collaboration with Oxford University, has also been found by researchers to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) — a rare but fatal blood clotting disorder.

(IANS)

ShareTweetSendSharePinShareSend
Previous Post

Slovakian PM Fico Hit By Four Bullets, Still ‘Serious’: Deputy PM

Next Post

Hajipur Lok Sabha Seat A Litmus Test For Chirag Paswan

Related Posts

Nation

India’s First Free Cancer Vaccination Programme For Girls Aged 1-14 In TN Soon: Minister Subramanian

October 26, 2025
Science & Tech

Rashtriya Vigyan Puraskar 2025 Announced, Honours India’s Top Scientists And Innovators

October 26, 2025
Google
Science & Tech

Google Expands India-First Agricultural AI APIs To APAC Countries

October 24, 2025
Dr. V. Narayanan
Science & Tech

ISRO To Launch US’ Bluebird-6 Satellite, Weighing 6.5 Tonnes By Year-End: Dr. V. Narayanan

October 23, 2025
Chip Design
Science & Tech

India’s Effort To Develop 7 Nm Processor Will Boost Chip Design Capabilities: Govt

October 22, 2025
Dementia Risk
Science & Tech

Some Anti-Allergy Drugs May Raise Dementia Risk In Elderly: Study

October 22, 2025
Next Post

Hajipur Lok Sabha Seat A Litmus Test For Chirag Paswan

Bangladesh Approves $23 Bn Annual Development Expenditure

J&K: NIA Attaches Pulwama Properties Of Jaish Terrorist

KHIMJI
OMC
  • Feedback
  • RSS Feed
  • Sitemap

© 2025 - Ommcom News. All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Home
  • Odisha
  • Nation
  • World
  • Sports
  • Business
  • Entertainment
  • Videos
  • Science & Tech
  • Photo Gallery
  • ଓଡ଼ିଆରେ ପଢନ୍ତୁ

© 2025 - Ommcom News. All Rights Reserved.